Cultured plant cells are useful for propagating rare plants and for studying the biosynthesis of secondary metabolites, such as flavors, pigments, and agrochemicals. To date, the biotransformation of various organic compounds has been investigated for the biotechnological application of plant cultured cells. The reactions involved in the biotransformation of organic compounds by cultured plant cells include oxidation, reduction, hydroxylation, esterification, methylation, isomerization, hydrolysis, and glycosylation [2] [3] [4] [5] [6] [7] [8] . Glycosylation occurs readily in plant cells, i.e., many kinds of secondary metabolites, such as saponins and anthocyanins are produced in the form of glycosides in higher plants and most of them are accumulated in the vacuole of cells. Many of these secondary metabolites have specific physiological activities and have been widely used in folk medicines [5] . The glycosylation reaction is catalyzed by glycosyltransferases, which occur widely in plants. Therefore, the glycosylation of organic compounds by plant glucosyltransferases is of pharmaceutical importance. In addition, glycosylation by plant glycosyltransferases has been the subject of increasing attention, since a one-step enzymatic glycosylation by plant glycosyltransferases is more convenient than chemical glycosylation, which requires tedious steps such as protection and deprotection of the hydroxyl groups of the sugar moieties. Although studies on glycosylation of resveratrol by plant glycosyltransferases have been reported [9] , there are few reports on synthesis of oligosaccharide-glycosides of resveratrol. Herein we report, for the first time, the glycosylation of resveratrol by plant glycosyltransferase and cyclodextrin glucanotransferase (CGTase) to give its oligosaccharide-glycosides. The glucosyltransferase (PaGT3), which we had isolated from P. americana [10] , was used as a biocatalyst in this experiment. PaGT3 was expressed in Escherichia coli, as described in the Experimental section. PaGT3 was purified using a His-accept column. The substrate, resveratrol (1, 50 M), and UDP-glucose (100 M) were administered to a conical flask containing 5 M PaGT3 and 50 mM potassium phosphate buffer (pH 7.2, 5mL), and the flask was incubated at 35°C for 24 h on a rotary shaker. After the incubation period, the reaction was stopped by adding 1.5% trifluoroacetic acid to the reaction mixture. Compounds 2 and 3 were isolated from the extracts of the reaction mixture with nBuOH. The chemical structures of the products were determined on the basis of their FABMS, (7) (IC 50 =176 M) were lower than that of 4, the glycosylation of resveratrol (1) improved its PDE inhibitory activity (IC 50 =187 M). The PDE inhibitor has been reported to reduce the severity levodopa-induced dyskinesias [9] . Therefore, PDE inhibitors show potential to exert a neuroprotective role, which could be particularly interesting for treatment of neurodegenerative disorders such as Alzheimer's disease. The resveratrol glycosides synthesized here could be potential chemopreventive agents for Alzheimer's disease. 
Experimental
General: HPLC was carried out with a Crest Pak C18S column (4.6 x 150 mm, JASCO Co. Jpn.) (detect: UV 288 nm; solvent: methanol/H 2 O/acetic acid=40/60/0.1; flow rate: 1 mL/min). Resveratrol used as a substrate was a gift from Ensuiko Co. MS was performed on a JEOL MS station JMS-700 spectrometer, and NMR spectra were obtained using a Varian XL-400 spectrometer.
Expression and purification of PaGT3: PaGT3 cDNA was cloned into pQE30, and the resulting plasmids were transformed into E. coli M15 cells. Expression and purification of PaGT3 were performed as described previously [10, 11] . The purified enzyme solution was dialyzed with 50 mM Tris-HCl (pH 7.2) containing 5 mM dithiothreitol, and stored at -80°C.
Glycosylation by PaGT3: Glucosylation reactions were performed at 35°C for 24 h in 5 mL of 50 mM potassium phosphate buffer (pH 7.2) supplemented with 50 M substrate, 100 M UDP-glucose, and 5 M enzyme. The incubation was stopped by adding 1.5% trifluoroacetic acid; the reaction mixture was analyzed by HPLC. The reaction mixture was extracted with n-BuOH. The n-BuOH fraction was concentrated by evaporation and the residue was dissolved in water. The water fraction was applied to Diaion HP20, washed with water, and eluted with methanol. The methanol solution was subjected to preparative HPLC.
Glycosylation by CGTase:
Resveratrol 4'-O--D-glucoside (3, 50 mg) was incubated with CGTase (300 U) in 10 mL of 50 mM citrate buffer solution (pH 5.6) containing 5 g of α-cyclodextrin at 37°C for 24 h. After incubation, the reaction mixture was centrifuged at 3000 g for 10 min. The supernatant was applied to a Sephadex G-25 column equilibrated with water. Fractions that contained glycosides were lyophilized, re-dissolved in water, and purified by preparative HPLC using a YMC-Pack R&D ODS column (150 m x 30 mm).
Phosphodiesterase assay: BIOMOL Green, which is used for calculation of the amount of phosphate released, was purchased from Funakoshi Co. PDE activity was measured by using a cyclic nucleotide phosphodiesterase assay kit from Enzo Life Sciences according to the manufacturer's instructions, except that PDE 100 mU per well was used. Stock solutions of inhibitors were prepared as 100 mM in DMSO and diluted to the appropriate concentrations. In the assay, 1 µL of each inhibitor solution was added before the addition of PDE enzyme solution. The PDE reaction was conducted at 37°C for 60 min and terminated by the addition of BIOMOL Green and further incubation at room temperature for 30 min. The color reaction was measured by reading OD at 620 nm with a Multiscan FC.
